Guggenheim Downgrades Macrogenics to Neutral
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Kelsey Goodwin has downgraded Macrogenics (NASDAQ:MGNX) from Buy to Neutral.
July 31, 2024 | 10:09 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Guggenheim analyst Kelsey Goodwin has downgraded Macrogenics from Buy to Neutral, which may lead to a short-term negative impact on the stock price.
The downgrade from Buy to Neutral by a reputable analyst can lead to a decrease in investor confidence and a potential short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100